Johanniskraut-Trockenextrakt Madaus

St. John's Wort Dry Extract, the active ingredient in Johanniskraut-Trockenextrakt Madaus, is a herbal drug presented as a dry extract for oral use. It is used to support mood in adults with mild to moderate depressive symptoms and seasonal affective disorder. GNH USA supplies Johanniskraut-Trockenextrakt Madaus as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Johanniskraut-Trockenextrakt Madaus, a St. John's Wort dry extract, is employed in the management of mood‑related conditions.

- Mild to moderate depression: alleviates depressive symptoms in adults. - Seasonal affective disorder: reduces mood decline associated with seasonal changes. - Subthreshold depressive symptoms: supports overall emotional balance.

Common Side Effects: - Gastrointestinal discomfort: nausea, stomach upset. - Dizziness or light‑headedness. - Fatigue or mild drowsiness. - Dry mouth. - Headache. - Increased sensitivity to sunlight (photosensitivity).

Serious or Rare Side Effects: - Serotonin syndrome when combined with serotonergic drugs. - Severe allergic reactions, including rash or angioedema. - Significant liver enzyme elevation. - Manic or hypomanic episodes in susceptible individuals. - Marked photosensitivity leading to severe sunburn.

Johanniskraut-Trockenextrakt Madaus should be used with caution in specific situations.

- Pregnancy and lactation: safety not established; avoid unless prescribed. - Concomitant serotonergic agents: risk of serotonin syndrome; monitor closely. - Photosensitivity: limit exposure to strong sunlight and use protective clothing. - Liver disease: use with caution; monitor hepatic function. - Drug interactions: review all concurrent medications before initiating therapy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Johanniskraut-Trockenextrakt Madaus can affect the metabolism of several medicines.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): potential for hypertensive crisis and serotonin excess. - Oral contraceptives: reduced efficacy, risk of unintended pregnancy.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, monitor INR. - Antiepileptic drugs (e.g., phenytoin): decreased plasma levels, monitor seizure control.